REGENXBIO Inc. (RGNX) Stock Analysis
Free AI-powered analysis and research for REGENXBIO Inc. stock
Sector: Healthcare
Full RGNX report
REGENXBIO Inc. (RGNX) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze RGNX Now βπ° Latest Update
Wall Street Analysts See a 214.55% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?
Wed, November 4, 2026 at 1:55 PM UTC 2 min read
Regenxbio (RGNX) closed at $7.63, with Wall Street analysts projecting a mean price target of $24, suggesting a potential upside of 214.6%. The targets range from $10.00 to $50.00, with a standard deviation of $11.67, indicating a consensus among analysts about the stock's direction. Despite the optimistic outlook, the article cautions that price targets should be approached with skepticism, as they may not accurately predict actual stock movements.